Literature DB >> 9516943

Phagocytosis of cross-linked gelatin matrix by human breast carcinoma cells correlates with their invasive capacity.

P J Coopman1, M T Do, E W Thompson, S C Mueller.   

Abstract

During invasion and metastasis, cancer cells interact closely with the extracellular matrix molecules by attachment, degradation, and migration. We demonstrated previously the local degradation of fluorescently labeled gelatin matrix by cancer cells at invasive membrane protrusions, called invadopodia. Using the newly developed quantitative fluorescence-activated cell sorting-phagocytosis assay and image analysis of localized degradation of fluorescently labeled matrix, we document here that degradation and site-specific removal of cross-linked gelatin matrix is correlated with the extent of phagocytosis in human breast cancer cells. A higher phagocytic capacity is generally associated with increasing invasiveness, documented in other invasion and motility assays as well. Gelatin phagocytosis is time and cell density dependent, and it is mediated by the actin cytoskeleton. Most of the intracellular gelatin is routed to actively acidified vesicles, as demonstrated by the fluorescent colocalization of gelatin with acidic vesicles, indicating the intracellular degradation of the phagocytosed matrix in lysosomes. We show here that normal intracellular routing is blocked after treatment with acidification inhibitors. In addition, the need for partial proteolytic degradation of the matrix prior to phagocytosis is demonstrated by the inhibition of gelatin phagocytosis with different serine and metalloproteinase inhibitors and its stimulation by conditioned medium containing the matrix metalloproteinases MMP-2 and MMP-9. Our results demonstrate that phagocytosis of extracellular matrix is an inherent feature of breast tumor cells that correlates with and may even directly contribute to their invasive capacity. This assay is useful for screening and evaluating potential anti-invasive agents because it is fast, reproducible, and versatile.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9516943

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  58 in total

Review 1.  Invadopodia: specialized cell structures for cancer invasion.

Authors:  Alissa M Weaver
Journal:  Clin Exp Metastasis       Date:  2006-07-09       Impact factor: 5.150

2.  CIN85, a Cbl-interacting protein, is a component of AMAP1-mediated breast cancer invasion machinery.

Authors:  Jin-Min Nam; Yasuhito Onodera; Yuichi Mazaki; Hiroyuki Miyoshi; Shigeru Hashimoto; Hisataka Sabe
Journal:  EMBO J       Date:  2007-01-25       Impact factor: 11.598

3.  RNA-binding IMPs promote cell adhesion and invadopodia formation.

Authors:  Jonas Vikesaa; Thomas V O Hansen; Lars Jønson; Rehannah Borup; Ulla M Wewer; Jan Christiansen; Finn C Nielsen
Journal:  EMBO J       Date:  2006-03-16       Impact factor: 11.598

Review 4.  Signaling inputs to invadopodia and podosomes.

Authors:  Daisuke Hoshino; Kevin M Branch; Alissa M Weaver
Journal:  J Cell Sci       Date:  2013-07-10       Impact factor: 5.285

5.  Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities.

Authors:  Yasuhito Onodera; Shigeru Hashimoto; Ari Hashimoto; Masaki Morishige; Yuichi Mazaki; Atsuko Yamada; Eiji Ogawa; Masashi Adachi; Takaki Sakurai; Toshiaki Manabe; Hiromi Wada; Nariaki Matsuura; Hisataka Sabe
Journal:  EMBO J       Date:  2005-02-17       Impact factor: 11.598

6.  Laminin-411 and -511 Modulate the Proliferation, Adhesion, and Morphology of Gastric Cancer Cells.

Authors:  Masaya Iwamuro; Hidenori Shiraha; Atsushi Oyama; Daisuke Uchida; Shigeru Horiguchi; Hiroyuki Okada
Journal:  Cell Biochem Biophys       Date:  2021-02-25       Impact factor: 2.194

7.  Requirement for Arf6 in breast cancer invasive activities.

Authors:  Shigeru Hashimoto; Yasuhito Onodera; Ari Hashimoto; Miwa Tanaka; Michinari Hamaguchi; Atsuko Yamada; Hisataka Sabe
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-15       Impact factor: 11.205

8.  Mechanically tunable coaxial electrospun models of YAP/TAZ mechanoresponse and IGF-1R activation in osteosarcoma.

Authors:  Eric R Molina; Letitia K Chim; Maria C Salazar; Shail M Mehta; Brian A Menegaz; Salah-Eddine Lamhamedi-Cherradi; Tejus Satish; Sana Mohiuddin; David McCall; Ana Maria Zaske; Branko Cuglievan; Alexander J Lazar; David W Scott; Jane K Grande-Allen; Joseph A Ludwig; Antonios G Mikos
Journal:  Acta Biomater       Date:  2019-09-19       Impact factor: 8.947

9.  Tumor suppressor function of Syk in human MCF10A in vitro and normal mouse mammary epithelium in vivo.

Authors:  You Me Sung; Xuehua Xu; Junfeng Sun; Duane Mueller; Kinza Sentissi; Peter Johnson; Elana Urbach; Françoise Seillier-Moiseiwitsch; Michael D Johnson; Susette C Mueller
Journal:  PLoS One       Date:  2009-10-15       Impact factor: 3.240

Review 10.  The EGFR-GEP100-Arf6-AMAP1 signaling pathway specific to breast cancer invasion and metastasis.

Authors:  Hisataka Sabe; Shigeru Hashimoto; Masaki Morishige; Eiji Ogawa; Ari Hashimoto; Jin-Min Nam; Koichi Miura; Hajime Yano; Yasuhito Onodera
Journal:  Traffic       Date:  2009-04-21       Impact factor: 6.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.